Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients

Steven E Lipshultz, Stacy D. Fisher, Wyman W. Lai, Tracie L Miller

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

Cardiovascular complications are important contributors to morbidity and mortality in HIV-infected patients. These complications can usually be detected at subclinical levels with monitoring, which can help guide targeted interventions. This article reviews available data on types and frequency of cardiovascular manifestations in HIV-infected patients and proposes monitoring strategies aimed at early subclinical detection. In particular, we recommend routine echocardiography for HIV-infected patients, even those with no evidence of cardiovascular disease. We also review preventive and therapeutic cardiovascular interventions. For procedures that have not been studied in HIV-infected patients, we extrapolate from evidence-based guidelines for the general population.

Original languageEnglish
JournalAIDS
Volume17
Issue numberSUPPL. 1
StatePublished - Apr 1 2003
Externally publishedYes

Fingerprint

HIV
monitoring
morbidity
evidence
mortality
Disease
Physiologic Monitoring
Therapeutics
Echocardiography
Cardiovascular Diseases
Guidelines
Morbidity
Mortality
Population

Keywords

  • AIDS
  • Atherosclerosis
  • Cardiomyopathy
  • Cardiovascular preventive care
  • Congestive heart failure
  • Guidelines
  • HIV
  • Lipodystrophy
  • Pericarditis

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology
  • Infectious Diseases
  • Health(social science)

Cite this

Lipshultz, S. E., Fisher, S. D., Lai, W. W., & Miller, T. L. (2003). Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS, 17(SUPPL. 1).

Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. / Lipshultz, Steven E; Fisher, Stacy D.; Lai, Wyman W.; Miller, Tracie L.

In: AIDS, Vol. 17, No. SUPPL. 1, 01.04.2003.

Research output: Contribution to journalArticle

Lipshultz, SE, Fisher, SD, Lai, WW & Miller, TL 2003, 'Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients', AIDS, vol. 17, no. SUPPL. 1.
Lipshultz SE, Fisher SD, Lai WW, Miller TL. Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. AIDS. 2003 Apr 1;17(SUPPL. 1).
Lipshultz, Steven E ; Fisher, Stacy D. ; Lai, Wyman W. ; Miller, Tracie L. / Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients. In: AIDS. 2003 ; Vol. 17, No. SUPPL. 1.
@article{0cfcf7a1b8ea4690be599aede47d3797,
title = "Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients",
abstract = "Cardiovascular complications are important contributors to morbidity and mortality in HIV-infected patients. These complications can usually be detected at subclinical levels with monitoring, which can help guide targeted interventions. This article reviews available data on types and frequency of cardiovascular manifestations in HIV-infected patients and proposes monitoring strategies aimed at early subclinical detection. In particular, we recommend routine echocardiography for HIV-infected patients, even those with no evidence of cardiovascular disease. We also review preventive and therapeutic cardiovascular interventions. For procedures that have not been studied in HIV-infected patients, we extrapolate from evidence-based guidelines for the general population.",
keywords = "AIDS, Atherosclerosis, Cardiomyopathy, Cardiovascular preventive care, Congestive heart failure, Guidelines, HIV, Lipodystrophy, Pericarditis",
author = "Lipshultz, {Steven E} and Fisher, {Stacy D.} and Lai, {Wyman W.} and Miller, {Tracie L}",
year = "2003",
month = "4",
day = "1",
language = "English",
volume = "17",
journal = "AIDS",
issn = "0269-9370",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Cardiovascular risk factors, monitoring, and therapy for HIV-infected patients

AU - Lipshultz, Steven E

AU - Fisher, Stacy D.

AU - Lai, Wyman W.

AU - Miller, Tracie L

PY - 2003/4/1

Y1 - 2003/4/1

N2 - Cardiovascular complications are important contributors to morbidity and mortality in HIV-infected patients. These complications can usually be detected at subclinical levels with monitoring, which can help guide targeted interventions. This article reviews available data on types and frequency of cardiovascular manifestations in HIV-infected patients and proposes monitoring strategies aimed at early subclinical detection. In particular, we recommend routine echocardiography for HIV-infected patients, even those with no evidence of cardiovascular disease. We also review preventive and therapeutic cardiovascular interventions. For procedures that have not been studied in HIV-infected patients, we extrapolate from evidence-based guidelines for the general population.

AB - Cardiovascular complications are important contributors to morbidity and mortality in HIV-infected patients. These complications can usually be detected at subclinical levels with monitoring, which can help guide targeted interventions. This article reviews available data on types and frequency of cardiovascular manifestations in HIV-infected patients and proposes monitoring strategies aimed at early subclinical detection. In particular, we recommend routine echocardiography for HIV-infected patients, even those with no evidence of cardiovascular disease. We also review preventive and therapeutic cardiovascular interventions. For procedures that have not been studied in HIV-infected patients, we extrapolate from evidence-based guidelines for the general population.

KW - AIDS

KW - Atherosclerosis

KW - Cardiomyopathy

KW - Cardiovascular preventive care

KW - Congestive heart failure

KW - Guidelines

KW - HIV

KW - Lipodystrophy

KW - Pericarditis

UR - http://www.scopus.com/inward/record.url?scp=0038543064&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038543064&partnerID=8YFLogxK

M3 - Article

VL - 17

JO - AIDS

JF - AIDS

SN - 0269-9370

IS - SUPPL. 1

ER -